262 related articles for article (PubMed ID: 16328383)
1. Characterization of the gammadelta T cell response to acute leukemia.
Meeh PF; King M; O'Brien RL; Muga S; Buckhalts P; Neuberg R; Lamb LS
Cancer Immunol Immunother; 2006 Sep; 55(9):1072-80. PubMed ID: 16328383
[TBL] [Abstract][Full Text] [Related]
2. Human gammadelta(+) T lymphocytes have in vitro graft vs leukemia activity in the absence of an allogeneic response.
Lamb LS; Musk P; Ye Z; van Rhee F; Geier SS; Tong JJ; King KM; Henslee-Downey PJ
Bone Marrow Transplant; 2001 Mar; 27(6):601-6. PubMed ID: 11319589
[TBL] [Abstract][Full Text] [Related]
3. Reconstitution of gammadelta T cell repertoire diversity after human allogeneic hematopoietic cell transplantation and the role of peripheral expansion of mature T cell population in the graft.
Hirokawa M; Horiuchi T; Kawabata Y; Kitabayashi A; Miura AB
Bone Marrow Transplant; 2000 Jul; 26(2):177-85. PubMed ID: 10918428
[TBL] [Abstract][Full Text] [Related]
4. Flow cytometric assessment of autologous gammadelta T cells in patients with acute myeloid leukemia: potential effector cells for immunotherapy?
Aswald JM; Wang XH; Aswald S; Lutynski A; Minden MD; Messner HA; Keating A
Cytometry B Clin Cytom; 2006 Nov; 70(6):379-90. PubMed ID: 16977635
[TBL] [Abstract][Full Text] [Related]
5. Distinct gene expression in human Vdelta1 and Vdelta2 gammadelta T cells following non-TCR agonist stimulation.
Kress E; Hedges JF; Jutila MA
Mol Immunol; 2006 May; 43(12):2002-11. PubMed ID: 16423401
[TBL] [Abstract][Full Text] [Related]
6. Type I IFN-mediated enhancement of anti-leukemic cytotoxicity of gammadelta T cells expanded from peripheral blood cells by stimulation with zoledronate.
Watanabe N; Narita M; Yokoyama A; Sekiguchi A; Saito A; Tochiki N; Furukawa T; Toba K; Aizawa Y; Takahashi M
Cytotherapy; 2006; 8(2):118-29. PubMed ID: 16698685
[TBL] [Abstract][Full Text] [Related]
7. Molecular diversity of gammadelta T cells in peripheral blood from patients with B-cell chronic lymphocytic leukaemia.
Bartkowiak J; Kulczyck-Wojdala D; Blonski JZ; Robak T
Neoplasma; 2002; 49(2):86-90. PubMed ID: 12088111
[TBL] [Abstract][Full Text] [Related]
8. Vdelta1 T lymphocytes from B-CLL patients recognize ULBP3 expressed on leukemic B cells and up-regulated by trans-retinoic acid.
Poggi A; Venturino C; Catellani S; Clavio M; Miglino M; Gobbi M; Steinle A; Ghia P; Stella S; Caligaris-Cappio F; Zocchi MR
Cancer Res; 2004 Dec; 64(24):9172-9. PubMed ID: 15604289
[TBL] [Abstract][Full Text] [Related]
9. Numerical and functional alterations of circulating gammadelta T lymphocytes in aged people and centenarians.
Argentati K; Re F; Donnini A; Tucci MG; Franceschi C; Bartozzi B; Bernardini G; Provinciali M
J Leukoc Biol; 2002 Jul; 72(1):65-71. PubMed ID: 12101264
[TBL] [Abstract][Full Text] [Related]
10. Oligoclonality of Vdelta1 and Vdelta2 cells in human peripheral blood mononuclear cells: TCR selection is not altered by stimulation with gram-negative bacteria.
Shen J; Andrews DM; Pandolfi F; Boyle LA; Kersten CM; Blatman RN; Kurnick JT
J Immunol; 1998 Mar; 160(6):3048-55. PubMed ID: 9510210
[TBL] [Abstract][Full Text] [Related]
11. Heat shock protein induced TCR gammadelta gene rearrangements in patients with oral cancer.
Wadia P; Atre N; Pradhan T; Mistry R; Chiplunkar S
Oral Oncol; 2005 Feb; 41(2):175-82. PubMed ID: 15695120
[TBL] [Abstract][Full Text] [Related]
12. Regulatory gamma delta T cells in Heymann nephritis express an invariant Vgamma6/Vdelta1 with a canonical CDR3 sequence.
Wu H; Knight JF; Alexander SI
Eur J Immunol; 2004 Aug; 34(8):2322-30. PubMed ID: 15259030
[TBL] [Abstract][Full Text] [Related]
13. A variant of SCID with specific immune responses and predominance of gamma delta T cells.
Ehl S; Schwarz K; Enders A; Duffner U; Pannicke U; Kühr J; Mascart F; Schmitt-Graeff A; Niemeyer C; Fisch P
J Clin Invest; 2005 Nov; 115(11):3140-8. PubMed ID: 16211094
[TBL] [Abstract][Full Text] [Related]
14. Hepatosplenic gammadelta T-cell lymphoma following seven malaria infections.
Hassan R; Franco SA; Stefanoff CG; Romano SO; Diamond HR; Franco LG; Seuánez HN; Zalcberg IR
Pathol Int; 2006 Nov; 56(11):668-73. PubMed ID: 17040289
[TBL] [Abstract][Full Text] [Related]
15. Identification of HLA-unrestricted CD8+/CD28- cytotoxic T-cell clones specific for leukemic blasts in children with acute leukemia.
Montagna D; Aricò M; Montini E; De Benedetti F; Maccario R
Cancer Res; 1995 Sep; 55(17):3835-9. PubMed ID: 7641201
[TBL] [Abstract][Full Text] [Related]
16. Vdelta1 T cell receptor binds specifically to MHC I chain related A: molecular and biochemical evidences.
Zhao J; Huang J; Chen H; Cui L; He W
Biochem Biophys Res Commun; 2006 Jan; 339(1):232-40. PubMed ID: 16297874
[TBL] [Abstract][Full Text] [Related]
17. Alphabeta T-cell receptor engineered gammadelta T cells mediate effective antileukemic reactivity.
van der Veken LT; Hagedoorn RS; van Loenen MM; Willemze R; Falkenburg JH; Heemskerk MH
Cancer Res; 2006 Mar; 66(6):3331-7. PubMed ID: 16540688
[TBL] [Abstract][Full Text] [Related]
18. Vdelta1 and Vdelta2 gammadelta T cells express distinct surface markers and might be developmentally distinct lineages.
De Rosa SC; Mitra DK; Watanabe N; Herzenberg LA; Herzenberg LA; Roederer M
J Leukoc Biol; 2001 Oct; 70(4):518-26. PubMed ID: 11590187
[TBL] [Abstract][Full Text] [Related]
19. Clinical grade expansion of CD45RA, CD45RO, and CD62L-positive T-cell lines from HLA-compatible donors: high cytotoxic potential against AML and ALL cells.
Barbui AM; Borleri G; Conti E; Ciocca A; Salvi A; Micò C; Introna M; Rambaldi A
Exp Hematol; 2006 Apr; 34(4):475-85. PubMed ID: 16569594
[TBL] [Abstract][Full Text] [Related]
20. Innate anti-breast cancer immunity of apoptosis-resistant human gammadelta-T cells.
Guo BL; Liu Z; Aldrich WA; Lopez RD
Breast Cancer Res Treat; 2005 Sep; 93(2):169-75. PubMed ID: 16187237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
